bluebird bio stock is ripe for a 400% institutional short squeeze
BLUEbluebird bio(BLUE) MarketBeat·2024-02-27 19:46

Key Points Healthcare stocks quietly build momentum to bring the market's next potential rally; not all stocks are created equal. bluebird Bio stock is a particular case in this space, calling for a massive upside in price targets, and institutional buying could create the next big short squeeze. Management has set up the scene, and the writing is on the wall for its upcoming earnings announcement. 5 stocks we like better than bluebird bio Maybe you are looking back at the 2020-2023 equity curve in your por ...